Previous Close | 75.03 |
Open | 75.00 |
Bid | 75.26 x 300 |
Ask | 75.34 x 500 |
Day's Range | 74.59 - 75.39 |
52 Week Range | 60.47 - 75.81 |
Volume | |
Avg. Volume | 6,384,256 |
Market Cap | 233.432B |
Beta (5Y Monthly) | 0.19 |
PE Ratio (TTM) | 37.09 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 1.45 (1.93%) |
Ex-Dividend Date | Feb 22, 2024 |
1y Target Est | N/A |
AstraZeneca CEO Pascal Soriot joined Yahoo Finance to discuss the company's earnings today.
Merck (MRK), Sanofi (SNY), Novartis (NVS) and AstraZeneca (AZN) announce their first-quarter results.
Fusion (FUSN) is expected to provide updates regarding the developmental program of its lead candidate, FPI-2265, for prostate cancer in the first-quarter earnings release.